MAP2K3 mouse monoclonal antibody,clone OTI5D3
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
Products
MAPK14 (Myc-DDK-tagged)-Human mitogen-activated protein kinase 14 (MAPK14), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
MAPK13 (Myc-DDK-tagged)-Human mitogen-activated protein kinase 13 (MAPK13)
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
MAPK11 (Myc-DDK-tagged)-Human mitogen-activated protein kinase 11 (MAPK11)
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
Anti-MAPK12 (SAPK3) mouse monoclonal antibody, clone OTI10E1 (formerly 10E1)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
MAPK14 (Myc-DDK-tagged)-Human mitogen-activated protein kinase 14 (MAPK14), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
Recombinant protein of human mitogen-activated protein kinase kinase kinase 5 (MAP3K5), 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
MAP2K6 (Myc-DDK-tagged)-Human mitogen-activated protein kinase kinase 6 (MAP2K6)
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
MAPK12 (Myc-DDK-tagged)-Human mitogen-activated protein kinase 12 (MAPK12)
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
MAP2K3 (Myc-DDK-tagged)-Human mitogen-activated protein kinase kinase 3 (MAP2K3), transcript variant B
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
MAPK13 (SAPK4) mouse monoclonal antibody, clone OTI12B2 (formerly 12B2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Recombinant protein of human mitogen-activated protein kinase 14 (MAPK14), transcript variant 1, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
MAP3K5 (Myc-DDK-tagged)-Human mitogen-activated protein kinase kinase kinase 5 (MAP3K5)
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
